2012-2020 (even years). Data from BRFSS for indicators of adult oral health for even years from 2012 through 2020. National estimates are represented by the median prevalence among 50 states and the District of Columbia data. Estimates are prepared from the BRFSS public use data sets. Estimates in this file are not age adjusted, and may differ slightly from estimates available from the BRFSS web site or Chronic Disease Indicators due to small differences in definition, age adjustment or rounding. For more information, see: https://www.cdc.gov/oralhealthdata/overview/Adult-Indicators.html.

National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention. Cumulative Influenza Vaccination Coverage and Intent for Vaccination Among Adults 18 Years and Older by Age, Race/Ethnicity, and COVID-19 Vaccination and Intent, United States; IPSOS Knowledge Panel and NORC AmeriSpeak Omnibus Surveys.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.

The Monthly Outcome Survey (MOS) was designed to assess COVID-19 vaccine uptake as well as beliefs, intentions, and behaviors relevant to COVID-19 vaccination at a point in time. The survey fielded on a monthly basis from January 2021 to April 2023. When the MOS first launched, it focused on the primary series of COVID-19 vaccines; in later waves, it was expanded to assess parents’ intentions to get their children vaccinated or boosted and to track booster and updated vaccine uptake and readiness. The MOS fielded as part of an online omnibus survey, conducted with a cross-sectional sample of approximately 5,000 U.S. adults each month.